stoxline Quote Chart Rank Option Currency Glossary
  
The Cooper Companies, Inc. (COO)
91.025  0.985 (1.09%)    04-23 11:27
Open: 89.98
High: 91.05
Volume: 163,174
  
Pre. Close: 90.04
Low: 89.98
Market Cap: 18,092(M)
Technical analysis
2024-04-23 10:47:22 AM
Short term     
Mid term     
Targets 6-month :  114.57 1-year :  120.85
Resists First :  98.09 Second :  103.47
Pivot price 94.28
Supports First :  89.41 Second :  74.38
MAs MA(5) :  90.27 MA(20) :  95.78
MA(100) :  94.68 MA(250) :  91.64
MACD MACD :  -2.5 Signal :  -1.8
%K %D K(14,3) :  8.2 D(3) :  7.1
RSI RSI(14): 29.2
52-week High :  104.06 Low :  75.93
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ COO ] has closed above bottom band by 25.8%. Bollinger Bands are 94.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 91.08 - 91.6 91.6 - 92.07
Low: 88.69 - 89.26 89.26 - 89.78
Close: 89.22 - 90.13 90.13 - 90.96
Company Description

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

Headline News

Sat, 20 Apr 2024
At US$90.42, Is It Time To Put The Cooper Companies, Inc. (NASDAQ:COO) On Your Watch List? - Yahoo Finance

Fri, 19 Apr 2024
Reasons to Hold The Cooper Companies (COO) in Your Portfolio Now - MSN

Wed, 17 Apr 2024
Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now? - Simply Wall St

Wed, 17 Apr 2024
Cooper Companies (NASDAQ:COO) Share Price Crosses Above Two Hundred Day Moving Average of $90.92 - MarketBeat

Tue, 02 Apr 2024
Cooper Companies (NASDAQ:COO) shareholders have earned a 6.5% CAGR over the last five years - Simply Wall St

Wed, 13 Mar 2024
Here's Why We Think The Cooper Companies, Inc.'s (NASDAQ:COO) CEO Compensation Looks Fair for the time being - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 199 (M)
Shares Float 197 (M)
Held by Insiders 0.5 (%)
Held by Institutions 100.5 (%)
Shares Short 2,180 (K)
Shares Short P.Month 2,970 (K)
Stock Financials
EPS 1.46
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 38.72
Profit Margin 7.9 %
Operating Margin 16.4 %
Return on Assets (ttm) 2.6 %
Return on Equity (ttm) 3.8 %
Qtrly Rev. Growth 8.5 %
Gross Profit (p.s.) 0
Sales Per Share 18.46
EBITDA (p.s.) 4.44
Qtrly Earnings Growth -4.5 %
Operating Cash Flow 564 (M)
Levered Free Cash Flow 138 (M)
Stock Valuations
PE Ratio 62.07
PEG Ratio 2.2
Price to Book value 2.34
Price to Sales 4.9
Price to Cash Flow 31.96
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android